Summary
It is well recognized that 5-HT1 -like receptors are heterogeneous and since in the radioligand studies at least four different 5-HT1 binding site subtypes (5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D) have been discriminated, four such receptor sites may well exist. Despite this multiplicity of 5-HT receptor subtypes, it appears that some 5-HT1 -like receptor-mediated functional responses, elicited by agonists such as 5-carboxamidotryptamine and blocked by methiothepin but not ketanserin, may not correspond to the above subtypes. These effects seem to include, among others, tachycardia in the cat, constriction of arteriovenous anastomoses in the pig and contraction of the rabbit isolated saphenous vein. In the cat heart the potency orders established for both the agonists (5-Carboxamidotryptamine > 5-HT ⋙ BEA 1654 ≫ 8-OH-DPAT=RU 24969=sumatriptan) and antagonists (methiothepin > methysergide > mesulergine ≫ metergoline ≫ mianserin > ketanserin > (±)propranolol) do not correlate with the order of affinity constants for any of the 5-HT1 binding site subtypes. Similarly, there are differences between the 5-HT1 -like receptors involved in the constriction of the porcine arteriovenous anastomoses and the rabbit saphenous vein and the 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D binding sites.
Supported by a Science and Technology grant from the EEC.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Born, A. H., Saxena, P. R., and Verdouw, P. D. (1988). Further characterization of the 5-HT, -like receptors in the carotid circulation of the pig. Br. J. Pharmacol. 94: 327P.
Born, A. H., Verdouw, P. D., and Saxena, P. R. (1989a). Carotid hemodynamics in pigs during infusions of 8-OH-DPAT: reduction in arteriovenous shunting is mediated by 5-HT,-like receptors. Br. J. Pharmacol. 96: 125–132.
Born, A. H., Villalón, C. M., Verdouw, P. D., and Saxena, P. R. (1989b). The 5-HT, -like receptor mediating reduction in porcine carotid arteriovenous shunting by RU 24969 is not related to either 5-HTIA or the 5-HT,B subtype. Eur. J. Pharmacol. 171: 87–96.
Bradley, P. B., Engel, G., Feniuk, W., Fozard, J. R., Humphrey, P. P. A., Middlemiss, D. N., Mylecharane, E. J., Richardson, B. P., and Saxena, P. R. (1986). Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacol. 25: 563–576.
Connor, H. E., Feniuk, W., Humphrey, P. P. A., and Perren, M. J. (1986). 5-Carboxamidotryptamine is a selective agonist at 5-hydroxytryptamine receptors mediating vasodilation and tachycardia in anaesthetized cats. Br. J. Pharmacol. 87: 417–426.
Den Boer, M. O., Villalón, C. M., Heiligers, J. P. C., Humphrey, P. P. A., and Saxena, P. R. (1991). Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan. Br. J. Pharmacol. 102: 323–330.
Gaddum, J. H., and Picarelli, Z. P. (1957). Two kinds of tryptamine receptors. Br. J. Pharmacol. 12: 323–328.
Heuring, R. E., and Peroutka, S. J. (1987). Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes. J. Neurosci. 7: 894–903.
Hoyer, D. (1989). 5-Hydroxytryptamine receptors and effector coupling mechanisms in peripheral tissues. In Fozard, J. R. (ed.), The peripheral actions of 5-hydroxytryptamine, Oxford: Oxford University Press, pp. 72–99.
Hoyer, D., Engel, G., and Kalkuran, H. O. (1985). Molecular pharmacology of 5-HT, and 5-HT, recognition sites in rat and pig brain membranes: radioligand binding studies with 3H 5-HT, 3H 8-OH-DPAT, (-)I251 iodocyanopindolol, 3H mesulergine and 3H ketanserin. Eur. J. Pharmacol. 118: 13–23.
Hoyer, D., Pazos, A., Probst, A., and Palacios, J. M. (1986). Serotonin receptors in the human brain II. Characterization and autoradiographic localization of 5-HT,c and 5-HT, recognition sites. Brain Res. 376: 97–107.
Hoyer, D., Waeber, C., Pazos, A., Probst, A., and Palacios, J. M. (1988). Identification of a 5-HT, recognition site in human brain membranes different from 5-HT,A, 5-HT,B and 5-HT lc sites. Neurosci. 85: 357–362.
Humphrey, P. P. A., Feniuk, W., Perren, M. J., Connor, H. E., Oxford, A. W., Coates, I. H., and Butina, D. (1988). GR43175, a selective agonist for the 5-HT,-like receptor in dog isolated saphenous vein. Br. J. Pharmacol. 94: 1123–1132.
Martin, G. R., and MacLennan, S. J. (1990). Analysis of the 5-HT receptor in rabbit saphenous vein exemplifies the problems of using exclusion criteria for receptor classification. Naunyn-Schm. Arch. Pharmacol. 342: 111–119.
Middlemiss, D. N., and Fozard, J. R. (1983). 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT, recognition site. Eur. J. Pharmacol. 90: 151–153.
Pazos, A., Hoyer, D., and Palacios, J. M. (1984). The binding of serotonergic ligands at the porcine choroid plexus: characterization of a new type of serotonin recognition site. Eur. J. Pharmacol. 106: 539–546.
Pedigo, N. W., Yamamura, H. I., and Nelson, D. L. (1981). Discrimination of multiple 3H-hydroxytryptamine-binding sites by the neuroleptic spiperone in rat brain. J. Neurochem. 36: 220–226.
Peroutka, S. J. (1986). Pharmacological differentiation and characterization of 5-HT,A, 5-HT,B and 5-HT lc binding sites in rat frontal cortex. J. Neurochem. 47: 529–540.
Perren, M. J., Feniuk, W., and Humphrey, P. P. A. (1991). Vascular 5-HT1-like receptors which mediate contraction of the dog is isolated saphenous vein and carotid arterial vasoconstriction in anaesthetised dogs are not of the 5-HTIA or 5-HTID subtype. Br. J. Pharmacol. In press.
Saxena, P. R. (1988). Further characterization of 5-hydroxytryptamine, -like receptors mediating tachycardia in the cat: no apparent relationship to known subtypes of the 5-hydroxytryptamine, binding site. Drug Dev. Res. 13: 245–258.
Saxena, P. R., and Verdouw, P. D. (1982). Redistribution by 5-hydroxytryptamine of carotid arterial blood at the expense of arteriovenous blood flow. J. Physiol. (Lond.) 332: 501–520.
Saxena, P. R., and Verdouw, P. D. (1984). Effects of methysergide and 5-hydroxytryptamine on carotid blood flow distribution in pigs: Further evidence for the presence of atypical 5-HT receptors. Br. J. Pharmacol. 82: 817–826.
Saxena, P. R., and Verdouw, P. D. (1985). 5-Carboxamide tryptamine, a compound with high affinity for 5-hydroxytryptamine, -like binding sites, dilates arterioles and constricts arteriovenous anastomoses. Br. J. Pharmacol. 84: 533–544.
Saxena, P. R., and Villalón, C. M. (1990). Cardiovascular effects of serotonin agonists and antagonists. J. Cardiovasc. Pharmacol. 15 (suppl. 7): S17–S35.
Saxena, P. R., Duncker, D. J., Bom, A. H., Heiligers, J., and Verdouw, P. D. (1986). Effects of MDL 72222 and methiothepin on carotid vascular responses to 5-hydroxytryptamine in the pig: Evidence for the presence of “5-hydroxytryptamine, -like” receptors. Naunyn-Schur. Arch. Pharmacol. 333: 198–204.
Saxena, P. R., Mylecharane, E. J., and Heiligers, J. (1985). Analysis of the heart rate effects of 5-hydroxytryptamine in the cat; mediation of tachycardia by 5-HT, -like receptors. Naunyn-Schur. Arch. Pharmacol. 330: 121–129.
Schoeffter, P., and Hoyer, D. (1998). How selective is GR 43175? Interactions with functional 5-HT,A, 5-HT,B, 5-HT,c and 5-HT,D receptors. Naunyn-Schm. Arch. Pharmacol. 340: 135–138.
Schoeffter, P., and Hoyer, D. (1990). 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT,D receptor subtype. J. Pharmacol. Exp. Ther. 252: 387–395.
Schoeffter, P., Waeber, C., Palacios, J. M., and Hoyer, D. (1988). The 5-hydroxytryptamine 5-HT,D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra. Naunyn-Schur. Arch. Pharmacol. 337: 602–608.
Trendelenburg, U. (1960). The action of histamine and 5-hydroxytryptamine on isolated mammalian atria. J. Pharmacol. Exp. Ther. 130: 450–460.
Van Heuven-Nolsen, D., Tysse Klasen, T. H. M., Luo, Q., and Saxena, P. R. (1990). 5-HT1-like receptors mediate contractions in the rabbit saphenous vein. Eur. J. Pharmacol. 191: 375–382.
Verdouw, P. D., Jennewein, H. M., Heiligers, J., Duncker, D. J., and Saxena, P. R. (1984). Redistribution of carotid artery blood flow by 5-HT: effects of the 5-HT2 receptor antagonists ketanserin and WAL 1307. Eur. J. Pharmacol. 102: 499–509.
Verdouw, P. D., Jennewein, H. M., Mierau, J., and Saxena, P. R. (1985). N-(3-acetylaminophenyl) piperazine hydrochloride (BEA 1654), a putative 5-HT, agonist, causes constriction of arteriovenous anastomoses and dilatation of arterioles. Eur. J. Pharmacol. 107: 337–346.
Villalón, C. M., Born, A. H., Heiligers, J., Den Boer, M. O., and Saxena, P. R. (1990). Constriction of porcine arteriovenous anastomoses by indorenate is unrelated to 5-HT1A, 5-HT,B, 5-HT,, or 5-HT,D receptor subtype. Eur. J. Pharmacol. 190: 167–176.
Waeber, C., Dietl, M. M., Hoyer, D., Probst, A., and Palacios, J. M. (1988a). Visualization of a novel serotonin recognition site (5-HT,D) in the human brain by autoradiography. Neurosci. Lett. 88: 11–16.
Waeber, C., Schoeffter, D., Palacios, J. M., and Hoyer, D. (1988b). Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes. Naunyn-Schm. Arch Pharmacol. 337: 595–601.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Birkhäuser Verlag Basel/Switzerland
About this chapter
Cite this chapter
van Heuven-Nolsen, D., Villalón, C.M., den Boer, M.O., Saxena, P.R. (1991). 5-HT1-Like Receptors Unrelated to the Known Binding Sites?. In: Fozard, J.R., Saxena, P.R. (eds) Serotonin: Molecular Biology, Receptors and Functional Effects. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7259-1_18
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7259-1_18
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-0348-7261-4
Online ISBN: 978-3-0348-7259-1
eBook Packages: Springer Book Archive